Geminin | List of Frontiers open access articles

Original Research

Published on 19 Dec 2022

Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression via EGFR-PI3K/Aurora-AThr288-geminin dual signaling pathways

in Experimental Pharmacology and Drug Discovery

Haile Zhao
Peijun Jia
Kathleen Nanding
Man Wu
Xiaozhou Bai
Morigen Morigen
Lifei Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1046269

4,364 views
8 citations

Original Research

Published on 29 Sep 2021

Lysophosphatidic Acid–Induced EGFR Transactivation Promotes Gastric Cancer Cell DNA Replication by Stabilizing Geminin in the S Phase

in Experimental Pharmacology and Drug Discovery

Haile Zhao
Gezi Gezi
Xiaoxia Tian
Peijun Jia
Morigen Morigen
Lifei Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.706240

3,718 views
5 citations

Original Research

Published on 25 Apr 2022

Small Molecule Inhibitor Targeting CDT1/Geminin Protein Complex Promotes DNA Damage and Cell Death in Cancer Cells

in Experimental Pharmacology and Drug Discovery

Nikolaos Karantzelis
Michalis Petropoulos
Valeria De Marco
David A. Egan
Alexander Fish
Evangelos Christodoulou
David W. Will
Joe D. Lewis
Anastassis Perrakis
Zoi Lygerou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.860682

7,337 views
12 citations

Review

Published on 25 Aug 2015

The Non-Canonical Role of Aurora-A in DNA Replication

in Molecular and Cellular Oncology

Takaaki Tsunematsu
Rieko Arakaki
Akiko Yamada
Naozumi Ishimaru
Yasusei Kudo

Frontiers in Oncology

doi 10.3389/fonc.2015.00187

6,845 views
9 citations

Original Research

Published on 26 Sep 2022

Live cell screening identifies glycosides as enhancers of cardiomyocyte cell cycle activity

in Cardiovascular Biologics and Regenerative Medicine

Ajit Magadum
Harsha V. Renikunta
Neha Singh
Conchi Estaras
Raj Kishore
Felix B. Engel

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.901396

4,101 views
5 citations

Original Research

Published on 25 Apr 2024

RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer

in Gynecological Oncology

Yoo-Na Kim
Kyeongmin Kim
Je-Gun Joung
Sang Wun Kim
Sunghoon Kim
Jung-Yun Lee
Eunhyang Park

Frontiers in Oncology

doi 10.3389/fonc.2024.1351778

4,198 views
6 citations

Articles

Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression via EGFR-PI3K/Aurora-AThr288-geminin dual signaling pathways

Lysophosphatidic Acid–Induced EGFR Transactivation Promotes Gastric Cancer Cell DNA Replication by Stabilizing Geminin in the S Phase

Small Molecule Inhibitor Targeting CDT1/Geminin Protein Complex Promotes DNA Damage and Cell Death in Cancer Cells

The Non-Canonical Role of Aurora-A in DNA Replication

Live cell screening identifies glycosides as enhancers of cardiomyocyte cell cycle activity

RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer